Lersivirine (UK-453061)(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.
Molecular Weight:
310.35
Purity:
98.01%
CAS Number:
[473921-12-9]
Formula:
C17H18N4O2
Target:
Reverse Transcriptase|||HIV Protease
T7700
* VAT and and shipping costs not included. Errors and price changes excepted